Associate Vice President, Clinical Affairs
Marlborough, Ma, Us
• Created an innovative patented method for using a surgical cutting device which revolutionized large core minimally invasive stereotactic biopsy. Resulted in market share increases for two medical equipment companies (Trex and US Surgical) with revenue of $50 million. (Patent # 5,830,219)• Led a world-class research team for a stereotactic breast biopsy research study. Resulted in a loyal group of luminary physicians which regularly wrote about the system in peer review journals and spoke about the system at mammography conferences. This resulted in greater credibility and overall image of Lorad and increased sales for the system.• Instrumental in the development of the Lorad Prone Stereotactic Breast Biopsy System, the Lorad M-IV, and the early development of the full field digital mammography system.• Inventor of 2 patents in the breast imaging field. Patent 5,706,327: Method and apparatus for mammographic compression. Patent 5,830,219: Apparatus for holding and driving a surgical cutting device using stereotactic mammography guidance.• Managed a stereotactic clinical trial consisting of 10 sites, 10 lead physicians, and over 1000 patients. Resulted in the largest study to date with the most influential physicians in mammography, over 60 peer-reviewed papers, and increased credibility and image in the market place for Lorad. • Guided and conducted initial trial of Full Field Digital Mammography under a 510k application. Resulted in company receiving approval for the protocol conducting trial and submitting trial results to the FDA.• Collaborated with sales, marketing, application specialists and engineering to develop the Lorad M-IV mammography system. This system rapidly became the market leader and remains the market leader still 10 years after its development.Note: This was originally Lorad and was later acquired by Hologic